Stephen A. Harrison
ORCID：0000-0001-8285-2204
发表论文 748 篇 · 总被引 69449 次 · h-index 117
代表论文
- Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study (2024 · Journal of Hepatology · 被引 151)
- Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial (2024 · The Lancet. Gastroenterology & hepatology · 被引 99)
- Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis (2024 · Nature Medicine · 被引 48)
- Integrating liver endpoints in clinical trials of cardiovascular and kidney disease (2024 · Nature Medicine · 被引 38)
- Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study (2025 · The Lancet · 被引 28)
- acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study (2024 · Clinical Gastroenterology and Hepatology · 被引 17)